These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8982674)

  • 41. Preparation and utility of a radioiodinated analogue of daunomycin in the study of multidrug resistance.
    Busche R; Tümmler B; Riordan JR; Cano-Gauci DF
    Mol Pharmacol; 1989 Apr; 35(4):414-21. PubMed ID: 2565017
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
    Muñoz-Martínez F; Lu P; Cortés-Selva F; Pérez-Victoria JM; Jiménez IA; Ravelo AG; Sharom FJ; Gamarro F; Castanys S
    Cancer Res; 2004 Oct; 64(19):7130-8. PubMed ID: 15466210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of verapamil and S9788 on MDR-1 mRNA expression studied by in situ hybridization.
    Joly P; Lallemand A; Oum'Hamed Z; Trentesaux C; Idoine O; Desplaces A
    Anticancer Res; 1996; 16(6B):3609-14. PubMed ID: 9042229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of the modality of exposure on the action of S9788 on the modulation of multidrug resistance of human tumor cell lines].
    Merlin JL; Marchal S; Ramacci C; Lucas C; Paraire M; Poullain MG
    Bull Cancer; 1994 Oct; 81(10):906-9. PubMed ID: 7734778
    [No Abstract]   [Full Text] [Related]  

  • 45. Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.
    Safa AR
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):1-17. PubMed ID: 14754408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of cytostatics and chemosensitizers with the dexniguldipine binding site on P-glycoprotein.
    Boer R; Ulrich WR; Haas S; Borchers C; Gekeler V; Boss H; Przybylski M; Schödl A
    Eur J Pharmacol; 1996 Jan; 295(2-3):253-60. PubMed ID: 8720592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities.
    Shapiro AB; Ling V
    Eur J Biochem; 1997 Nov; 250(1):130-7. PubMed ID: 9432000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of S9788 on the efficiency of doxorubicin in vivo and in vitro in medullary thyroid carcinoma xenograft.
    Massart C; Gibassier J; Raoul M; Denais A; Maugendre S; Darcel F; Lucas C
    Anticancer Drugs; 1996 May; 7(3):321-30. PubMed ID: 8792007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benzimidazoles, potent anti-mitotic drugs: substrates for the P-glycoprotein transporter in multidrug-resistant cells.
    Nare B; Liu Z; Prichard RK; Georges E
    Biochem Pharmacol; 1994 Dec; 48(12):2215-22. PubMed ID: 7811303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversal of multidrug resistance by a new lipophilic cationic molecule, S9788. Comparison with 11 other MDR-modulating agents in a model of doxorubicin-resistant rat glioblastoma cells.
    Huet S; Chapey C; Robert J
    Eur J Cancer; 1993; 29A(10):1377-83. PubMed ID: 8398262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter.
    Romsicki Y; Sharom FJ
    Biochemistry; 2001 Jun; 40(23):6937-47. PubMed ID: 11389609
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Enhancement of cytotoxic effect of anticancer agents of renal cell carcinoma].
    Okano M; Kawamoto S; Nezasa S; Tamaki M; Ehara H; Yamada S; Deguchi T; Kawada Y
    Nihon Hinyokika Gakkai Zasshi; 1996 Aug; 87(8):1041-7. PubMed ID: 8831211
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine.
    Ferry DR; Malkhandi PJ; Russell MA; Kerr DJ
    Biochem Pharmacol; 1995 Jun; 49(12):1851-61. PubMed ID: 7598747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.
    Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM
    Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil.
    Safa AR
    Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7187-91. PubMed ID: 2902625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
    Mankhetkorn S; Garnier-Suillerot A
    Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison between technetium-99m-sestamibi and hydrogen-3-daunomycin myocardial cellular retention in vitro.
    Cayre A; Moins N; Finat-Duclos F; Verrelle P; Maublant J
    J Nucl Med; 1997 Nov; 38(11):1674-7. PubMed ID: 9374331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells.
    Sharom FJ; Yu X; Chu JW; Doige CA
    Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):381-90. PubMed ID: 7772017
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and localization of three photobinding sites of iodoarylazidoprazosin in hamster P-glycoprotein.
    Isenberg B; Thole H; Tümmler B; Demmer A
    Eur J Biochem; 2001 May; 268(9):2629-34. PubMed ID: 11322883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overcoming multidrug resistance in human cancer cells by natural compounds.
    Nabekura T
    Toxins (Basel); 2010 Jun; 2(6):1207-24. PubMed ID: 22069634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.